183 related articles for article (PubMed ID: 37488394)
21. Neoadjuvant Simultaneous Integrated Boost Radiation Therapy Improves Clinical Outcomes for Retroperitoneal Sarcoma.
Liveringhouse CL; Palm RF; Bryant JM; Yang GQ; Mills MN; Figura ND; Ahmed KA; Mullinax J; Gonzalez R; Johnstone PA; Naghavi AO
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):123-138. PubMed ID: 36935026
[TBL] [Abstract][Full Text] [Related]
22. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.
Raut CP; Callegaro D; Miceli R; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss DC; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria S; Canter R; Mullen J; Gelderblom HJ; Pennacchioli E; van Coevorden F; Cardona K; Fiore M; Fairweather M; Gronchi A
Clin Cancer Res; 2019 Apr; 25(8):2664-2671. PubMed ID: 30723141
[TBL] [Abstract][Full Text] [Related]
23. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
[TBL] [Abstract][Full Text] [Related]
24. A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
Squires MH; Ethun CG; Donahue EE; Benbow JH; Anderson CJ; Jagosky MH; Salo JC; Hill JS; Ahrens W; Prabhu RS; Livingston MB; Gower NL; Needham M; Trufan SJ; Fields RC; Krasnick BA; Bedi M; Abbott DE; Schwartz P; Votanopoulos K; Chouliaras K; Grignol V; Roggin KK; Tseng J; Poultsides G; Tran TB; Cardona K; Howard JH
J Surg Oncol; 2021 Oct; 124(5):829-837. PubMed ID: 34254691
[TBL] [Abstract][Full Text] [Related]
25. Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.
Tseng W; Martinez SR; Tamurian RM; Borys D; Canter RJ
J Surg Res; 2012 Jan; 172(1):123-30. PubMed ID: 20869082
[TBL] [Abstract][Full Text] [Related]
26. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
[TBL] [Abstract][Full Text] [Related]
27. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
[TBL] [Abstract][Full Text] [Related]
28. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma.
Erstad DJ; Chiang YJ; Witt RG; Cope B; Nassif EF; Scally CP; Torres KE; Feig BW; Hunt KK; Bishop AJ; Guadagnolo BA; Roland CL; Keung EZ
Ann Surg Oncol; 2023 Feb; 30(2):926-940. PubMed ID: 36115928
[TBL] [Abstract][Full Text] [Related]
29. A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2).
Lambdin J; Ryan C; Gregory S; Cardona K; Hernandez JM; van Houdt WJ; Gronchi A
Ann Surg Oncol; 2023 Aug; 30(8):4573-4575. PubMed ID: 37170037
[TBL] [Abstract][Full Text] [Related]
30. The importance of surgical margins in retroperitoneal sarcoma.
Kirane A; Crago AM
J Surg Oncol; 2016 Mar; 113(3):270-6. PubMed ID: 26707028
[TBL] [Abstract][Full Text] [Related]
31. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
[TBL] [Abstract][Full Text] [Related]
32. Does compartmental resection really impact retroperitoneal soft tissue sarcomas? A retrospective analysis from a Single Referral Center.
Garcia-Ortega DY; Ortega Jiménez JA; Melendez-Fernandez AP; Álvarez-Cano A; Caro-Sanchez CHS; Vargas-Lara AK; Luna-Ortiz K
Surg Oncol; 2023 Dec; 51():101997. PubMed ID: 37832278
[TBL] [Abstract][Full Text] [Related]
33. [Retroperitoneal soft tissue sarcoma: role of radiotherapy].
Nieto A; Albertsmeier M; Werner J; Di Gioia D; Lindner LH; Rauch J; Nachbichler S; Belka C; Schmidt-Hegemann NS
Chirurg; 2022 Jan; 93(1):34-39. PubMed ID: 34524488
[TBL] [Abstract][Full Text] [Related]
34. The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas.
Nussbaum DP; Speicher PJ; Gulack BC; Ganapathi AM; Keenan JE; Stinnett SS; Kirsch DG; Tyler DS; Blazer DG
Surg Oncol; 2014 Sep; 23(3):155-60. PubMed ID: 25085344
[TBL] [Abstract][Full Text] [Related]
35. A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis.
Arthur A; Orton MR; Emsley R; Vit S; Kelly-Morland C; Strauss D; Lunn J; Doran S; Lmalem H; Nzokirantevye A; Litiere S; Bonvalot S; Haas R; Gronchi A; Van Gestel D; Ducassou A; Raut CP; Meeus P; Spalek M; Hatton M; Le Pechoux C; Thway K; Fisher C; Jones R; Huang PH; Messiou C
Lancet Oncol; 2023 Nov; 24(11):1277-1286. PubMed ID: 37922931
[TBL] [Abstract][Full Text] [Related]
36. Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results.
Callegaro D; Raut CP; Ajayi T; Strauss D; Bonvalot S; Ng D; Stoeckle E; Fairweather M; Rutkowski P; van Houdt WJ; Gelderblom H; Sangalli C; Hayes A; Honoré C; Gladdy RA; Fau M; Haas R; Tzanis D; Miah AB; Chung P; Baldini EH; Marreaud S; Litiere S; Swallow CJ; Gronchi A
Ann Surg; 2023 Jul; 278(1):127-134. PubMed ID: 35833413
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.
Haas RLM; Bonvalot S; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Gladdy R; Jakob J; Szacht M; Fiore M; Chung PW; van Houdt WJ; Raut CP; Gronchi A
Cancer; 2019 Apr; 125(8):1290-1300. PubMed ID: 30602058
[TBL] [Abstract][Full Text] [Related]
39. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
[TBL] [Abstract][Full Text] [Related]
40. [Retroperitoneal sarcomas: diagnostic and therapy].
Gockel I; Oberholzer K; Gönner U; Mantai S; Junginger T
Zentralbl Chir; 2006 Jun; 131(3):223-9. PubMed ID: 16739063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
